Inquire Before Buying - Dry Eye Syndrome Market - Share, Size, and Industry Trends, 2030

Global Dry Eye Syndrome Market Research Report: Forecast (2024-2030)

Dry Eye Syndrome Market- By Product (Artificial Tears, Anti-inflammatory drugs [Cyclosporine, Corticosteroid], Punctal Plugs [Disposable, Removable], Others), By Disease Type (Aque......ous Dry Eye, Evaporative Dry Eye), By Distribution Channel (Offline [Retail Pharmacies, Hospital Pharmacies], Online), By Region (North America, South America, Europe, The Middle East & Africa, Asia Pacific), By Company (Mitotech Pharma, ReGen Tree, Santen Pharmaceutical, HanAll Biopharma, Sun Pharma, Novaliq, Sylentis, Alcon, Horus pharma, Johnson& Johnson, Aldreya Therapeutics, Visufarma, Allergen, Prestige Consumer Health, Others) Read more

Healthcare
Jul 2023
Pages 194
Report Format: PDF, Excel, PPT

Market Definition

Dry eye disease (DED) is a common condition that occurs when the eyes do not produce enough tears or tears evaporate from the eyes. As tears are essential for keeping the eyes lubricated & nourished, if there is any imbalance in the tear film, it can cause itching, burning, inflammation, and damage to the cornea.

Market Insights & Analysis: Global Dry Eye Syndrome Market (2024-30):

The Global Dry Eye Syndrome Market size is valued at around USD 5.2 billion in 2023 and is projected to grow at a CAGR of around 4.21% during the forecast period, i.e., 2024-30. The growing incidence of this disease globally has been driving the demand for its drugs in the market since the historical years, and this trend is expected to flourish during the forthcoming period as well. Owing to the rise in the geriatric population, increased awareness of the diagnosis & treatment, and an upsurge in the usage of contact lenses, high screen time, etc., are some factors aiding in enhancing the market size.

However, the market expansion has been constrained by strict regulatory procedures for drug approval & the availability of alternative therapies, owing to which manufacturers are hesitant to develop new products due to the high investment cost in R&D, clinical trials, and regulatory burden associated with compliance.

Report Coverage	Details
Study Period	Historical Data: 2019-22
	Base Year: 2023
	Forecast Period: 2024-30
CAGR (2024-2030)	4.21%
Regions Covered	North America: US, Canada, Mexico
	Europe: Germany, The UK, France, Spain, Italy, Rest of Europe
	Asia-Pacific: China, India, Japan, South Korea, Australia, Rest of Asia-Pacific
	South America: Brazil, Argentina
	Middle East & Africa: UAE, Saudi Arabia, South Africa, Rest of MEA
Key Companies Profiled	Mitotech Pharma, ReGen Tree, Santen Pharmaceutical, HanAll Biopharma, Sun Pharma, Novaliq, Sylentis, Alcon, Horus pharma, Johnson& Johnson, Aldreya Therapeutics, Visufarma, Allergen, Prestige Consumer Health, Others
Market Value (2023)	USD 5.2 Billion

Moreover, due to the limited prescribed treatment options available, there is growing pressure to develop new therapies & healing treatments within the global market to treat this multifactorial ocular condition, which would eventually uplift the demand for drugs in the market. Furthermore, the surging investment by pharmaceutical companies to produce advanced emerging drugs for treating disease would assist the market growth in the following years. The prevalence of dry eye disease is higher in the incidence of other chronic health conditions, such as diabetes, rheumatic, etc., which can affect the functioning of the eye. Due to this, the changes in a patient's blood composition due to diabetes can adversely affect the tear glands, causing dry eye syndrome, which would gradually upscale the requirement for these drugs in the market.

Additionally, many diseases that can cause dry-eye syndrome indirectly include vitamin A deficiency, such as lupus, thyroid disease, etc. Thus, the growing occurrence of such diseases in patients would assist in the overall market growth in the ensuing years.

Market Segmentation
Introduction
1. Product Definition
2. Research Process
3. Assumptions
Executive Summary
Global Dry Eye Syndrome Market Background & Overview
Global Dry Eye Syndrome Epidemiology, Prevalence
1. By Gender
2. By Age
3. By Region
  1. North America
    1. By Gender
    2. By Age
  2. South America
    1. By Gender
    2. By Age
  3. Europe
    1. By Gender
    2. By Age
  4. Middle East & Africa
    1. By Gender
    2. By Age
  5. Asia Pacific
    1. By Gender
    2. By Age
Global Dry Eye Syndrome Market Guidelines and Standards
1. Manufacturing
2. Packaging & Labeling
Global Dry Eye Syndrome Market Patent Analysis, 2019-2023
1. Patents Granted, By Company
Global Dry Eye Syndrome Market Value Chain Analysis
Global Dry Eye Syndrome Market Porter Five Analysis
Global Dry Eye Syndrome Market Trends & Developments
Global Dry Eye Syndrome Market Dynamics
1. Drivers
2. Challenges
Global Dry Eye Syndrome Recent Developments
1. Marketed Drugs
  1. By Disease Type
2. Emerging Drugs
  1. By Disease Type
  2. By Clinical Phase
Global Dry Eye Syndrome Hotspot and Opportunities
Global Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Size & Analysis
  1. By Product
    1. Artificial Tears- Market Size & Forecast 2019-2030, USD Million
    2. Anti-inflammatory Drugs- Market Size & Forecast 2019-2030, USD Million
      1. Cyclosporine-- Market Size & Forecast 2019-2030, USD Million
      2. Corticosteroid-- Market Size & Forecast 2019-2030, USD Million
    3. Punctal Plugs- Market Size & Forecast 2019-2030, USD Million
      1. Dissolvable-- Market Size & Forecast 2019-2030, USD Million
      2. Removable-- Market Size & Forecast 2019-2030, USD Million
    4. Others (Secretagogues, Oral drugs, etc.)- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type
    1. Aqueous Dry Eye - Market Size & Forecast 2019-2030, USD Million
    2. Evaporative Dry Eye - Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel
    1. Offline- Market Size & Forecast 2019-2030, USD Million
      1. Retail Pharmacies- Market Size & Forecast 2019-2030, USD Million
      2. Hospital Pharmacies - Market Size & Forecast 2019-2030, USD Million
    2. Online- Market Size & Forecast 2019-2030, USD Million
  4. By Competition
    1. Competition Characteristics
    2. Market Share Analysis
  5. By Region
    1. North America
    2. South America
    3. Europe
    4. Middle East & Africa
    5. Asia-Pacific
North America Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. The US
    2. Canada
    3. Mexico
3. The US Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Canada Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. Mexico Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
South America Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. Brazil
    2. Argentina
3. Brazil Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Argentina Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Europe Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. Germany
    2. The UK
    3. France
    4. Spain
    5. Italy
    6. Rest of Europe
3. Germany Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. The UK Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. France Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. Spain Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. Italy Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Middle East & Africa Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. The UAE
    2. Saudi Arabia
    3. South Africa
    4. Rest of Middle East & Africa
3. The UAE Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Saudi Arabia Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. South Africa Eye Disease Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Asia-Pacific Dry Eye Syndrome Market Outlook, 2019-2030F
1. Market Size & Analysis
  1. By Revenues (USD Million)
2. Market Share & Analysis
  1. By Product- Market Size & Forecast 2019-2030, USD Million
  2. By Disease Type- Market Size & Forecast 2019-2030, USD Million
  3. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
  4. By Country
    1. China
    2. Japan
    3. South Korea
    4. Australia
    5. India
    6. Rest of Asia Pacific
3. China Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
4. Japan Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
5. South Korea Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
6. Australia Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
7. India Dry Eye Syndrome Market Outlook, 2019-2030F
  1. Market Size & Analysis
    1. By Revenues (USD Million)
  2. Market Share & Analysis
    1. By Product- Market Size & Forecast 2019-2030, USD Million
    2. By Distribution Channel- Market Size & Forecast 2019-2030, USD Million
Competitive Outlook
1. Company Profiles
  1. Mitotech Pharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  2. ReGen Tree
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  3. Santen Pharmaceutical
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  4. HanAll BioPharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  5. Sun Pharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  6. Novaliq
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  7. Sylentis
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  8. Alcon
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  9. Horus Pharma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  10. Johnson & Johnson
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  11. Alderya Therapeutics
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  12. Visufarma
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  13. Allergan
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  14. Prestige Consumer Health
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others
  15. Others
    1. Business Description
    2. Product Portfolio
    3. Strategic Alliances or Partnerships
    4. Recent Developments
    5. Financial Details
    6. Others.
Disclaimer

MarkNtel Advisors follows a robust and iterative research methodology designed to ensure maximum accuracy and minimize deviation in market estimates and forecasts. Our approach combines both bottom-up and top-down techniques to effectively segment and quantify various aspects of the market. A consistent feature across all our research reports is data triangulation, which examines the market from three distinct perspectives to validate findings. Key components of our research process include:

1. Scope & Research Design At the outset, MarkNtel Advisors define the research objectives and formulate pertinent questions. This phase involves determining the type of research—qualitative or quantitative—and designing a methodology that outlines data collection methods, target demographics, and analytical tools. They also establish timelines and budgets to ensure the research aligns with client goals.

2. Sample Selection and Data Collection In this stage, the firm identifies the target audience and determines the appropriate sample size to ensure representativeness. They employ various sampling methods, such as random or stratified sampling, based on the research objectives. Data collection is carried out using tools like surveys, interviews, and observations, ensuring the gathered data is reliable and relevant.

3. Data Analysis and Validation Once data is collected, MarkNtel Advisors undertake a rigorous analysis process. This includes cleaning the data to remove inconsistencies, employing statistical software for quantitative analysis, and thematic analysis for qualitative data. Validation steps are taken to ensure the accuracy and reliability of the findings, minimizing biases and errors.

4. Data Forecast and FinalizationThe final phase involves forecasting future market trends based on the analyzed data. MarkNtel Advisors utilize predictive modeling and time series analysis to anticipate market behaviors. The insights are then compiled into comprehensive reports, featuring visual aids like charts and graphs, and include strategic recommendations to inform client decision-making

FILL THE FORM TO INQUIRE BEFORE BUYING THIS REPORT

Name *

Email ID *

Country *

Contact Number *

Your Enquiry Details

Your data is 100% confidential & secure

By submitting, you agree to our Terms and Privacy Policy .

Flexible Licensing Options

We offer flexible licensing options to cater to varying organizational needs. Choose the pricing pack that best suits your requirements:

Buy Now

Related Reports

Talk to our Consultant

Customization Offered

Request Customization